In Canada, approximately 2,600 women are diagnosed with ovarian cancer on a yearly basis, and about 1,550 die of the disease. Ovarian cancer is the 6th most common cancer in women, and the 5th most common cause of cancer death for women in Canada. Unfortunately, ovarian cancer is very difficult to detect, and there are no good screening methods. Consequently, the majority of cases are diagnosed when the disease is somewhat advanced and more difficult to treat effectively. Ongoing research into ovarian cancer is absolutely vital if we are to find ways of preventing and curing this disease.

Ovarian Cancer Research Program
The Corinne Boyer Chair in Ovarian Cancer Research at the University of Ottawa was established in acknowledgement of the fact that there is a current lack of effective treatment for women with ovarian cancer, that the 5-year prognosis for women who become afflicted with the disease has not changed in 30 years, and that the number of scientists with research programs specifically directed to the study of ovarian biology and ovarian cancer is limited.

The primary objective of the Chair is to develop a strong and productive Ovarian Cancer Research Program. The goal is to foster the development of an integrated, innovative, multidisciplinary research program that will investigate the pathogenesis of ovarian cancer. With the appropriate collaborations, the knowledge generated from these studies can then be translated effectively into improved diagnostic and therapeutic strategies for women with ovarian cancer.

Dr. Vanderhyden is optimistic that all of the recent work in cancer research, including studies in genetic or viral therapy, may in some parts be transferable to the treatment of ovarian cancer. Our approach is not to start from scratch but to develop the platform and opportunities for scientists from all disciplines to share their work, and to find ways to transform this information into applicable treatments.

Please explore this website for more details on the Vision established by the Chair when she accepted this position, the ovarian cancer research conferences, the research projects that comprise the Ovarian Cancer Research Program, and sponsors of the Program.